212 related articles for article (PubMed ID: 20801521)
1. Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial.
Ying GS; Maguire MG;
Ophthalmology; 2011 Feb; 118(2):332-8. PubMed ID: 20801521
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.
Brader HS; Ying GS; Martin ER; Maguire MG;
Ophthalmology; 2013 Sep; 120(9):1871-9. PubMed ID: 23622873
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
[TBL] [Abstract][Full Text] [Related]
4. Night vision symptoms and progression of age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.
Ying GS; Maguire MG; Liu C; Antoszyk AN;
Ophthalmology; 2008 Nov; 115(11):1876-82. PubMed ID: 18672295
[TBL] [Abstract][Full Text] [Related]
5. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.
Maguire MG; Ying GS; McCannel CA; Liu C; Dai Y;
Ophthalmology; 2009 Dec; 116(12):2381-5. PubMed ID: 19850347
[TBL] [Abstract][Full Text] [Related]
6. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
Maguire M;
Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
[TBL] [Abstract][Full Text] [Related]
7. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.
Complications of Age-Related Macular Degeneration Prevention Trial Research Group
Ophthalmology; 2006 Nov; 113(11):1974-86. PubMed ID: 17074563
[TBL] [Abstract][Full Text] [Related]
8. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
Holekamp N; Wykoff CC; Schmitz-Valckenberg S; Monés J; Souied EH; Lin H; Rabena MD; Cantrell RA; Henry EC; Tang F; Swaminathan B; Martin J; Ferrara D; Staurenghi G
Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
[TBL] [Abstract][Full Text] [Related]
9. Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration.
Pfau M; von der Emde L; de Sisternes L; Hallak JA; Leng T; Schmitz-Valckenberg S; Holz FG; Fleckenstein M; Rubin DL
JAMA Ophthalmol; 2020 Oct; 138(10):1026-1034. PubMed ID: 32789526
[TBL] [Abstract][Full Text] [Related]
10. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
Rosenfeld PJ; Dugel PU; Holz FG; Heier JS; Pearlman JA; Novack RL; Csaky KG; Koester JM; Gregory JK; Kubota R
Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
Maguire MG; Alexander J; Fine SL;
Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
[TBL] [Abstract][Full Text] [Related]
12. Effect of Human Central Nervous System Stem Cell Subretinal Transplantation on Progression of Geographic Atrophy Secondary to Nonneovascular Age-Related Macular Degeneration.
Nittala MG; Uji A; Velaga SB; Hariri AH; Naor J; Birch DG; Spencer R; Leng T; Capela A; Tsukamoto A; Ip M; Sadda SR
Ophthalmol Retina; 2021 Jan; 5(1):32-40. PubMed ID: 32562884
[TBL] [Abstract][Full Text] [Related]
13. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
[TBL] [Abstract][Full Text] [Related]
14. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.
Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG
Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
[TBL] [Abstract][Full Text] [Related]
16. Choroidal signal hypertransmission on optical coherence tomography imaging: Association with development of geographic atrophy in age-related macular degeneration.
Wu Z; Terheyden JH; Hodgson LAB; Guymer RH
Clin Exp Ophthalmol; 2024; 52(4):431-439. PubMed ID: 38286571
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration.
Wu Z; Luu CD; Ayton LN; Goh JK; Lucci LM; Hubbard WC; Hageman JL; Hageman GS; Guymer RH
Ophthalmology; 2014 Dec; 121(12):2415-22. PubMed ID: 25109931
[TBL] [Abstract][Full Text] [Related]
18. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.
Ying GS; Maguire MG; Alexander J; Martin RW; Antoszyk AN;
Arch Ophthalmol; 2009 Sep; 127(9):1147-51. PubMed ID: 19752423
[TBL] [Abstract][Full Text] [Related]
19. Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report.
Wu Z; Luu CD; Hodgson LAB; Caruso E; Brassington KH; Tindill N; Aung KZ; Harper CA; Wickremasinghe SS; Sandhu SS; McGuinness MB; Chen FK; Chakravarthy U; Arnold JJ; Heriot WJ; Durkin SR; Wintergerst MWM; Gorgi Zadeh S; Schultz T; Finger RP; Cohn AC; Baglin EK; Sharangan P; Guymer RH;
Ophthalmol Retina; 2019 Dec; 3(12):1026-1034. PubMed ID: 31582304
[TBL] [Abstract][Full Text] [Related]
20. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
